Oncology · Lymphoma

Hodgkin Lymphoma

USMLE2PANCE
7

Bets

The facts most likely to be tested

1

The hallmark histologic finding of Hodgkin Lymphoma is the Reed-Sternberg cell, which is a large, multinucleated cell with owl-eye inclusions.

Confidence:
2

Patients frequently present with a painless, rubbery lymphadenopathy in the cervical or supraclavicular region, often exacerbated by alcohol-induced pain.

Confidence:
3

Systemic B symptoms, including unexplained fever, night sweats, and weight loss, are critical prognostic indicators and are associated with a worse outcome.

Confidence:
4

The disease follows a bimodal age distribution, with peaks occurring in young adulthood (ages 15–35) and in older adults (over age 55).

Confidence:
5

Diagnosis is confirmed via excisional lymph node biopsy, as fine-needle aspiration is insufficient to evaluate the nodular architecture.

Confidence:
6

The Ann Arbor staging system is used to determine the extent of disease, which dictates the intensity of chemotherapy (ABVD regimen) and radiation therapy.

Confidence:
7

Long-term survivors of Hodgkin Lymphoma are at significantly increased risk for secondary malignancies, particularly breast cancer and lung cancer, due to prior radiation exposure.

Confidence:

Vignette unlocked

A 24-year-old male presents to the clinic with a two-month history of a painless, rubbery mass in his left neck. He reports a 10-pound unintentional weight loss and drenching night sweats over the same period. He notes that the mass becomes tender after he consumes a glass of wine at dinner. Physical examination reveals a 3 cm supraclavicular lymph node and no hepatosplenomegaly.

What is the most likely diagnosis?

+Reveal answer

Hodgkin Lymphoma

The patient's presentation of B symptoms, painless cervical lymphadenopathy, and the classic pathognomonic finding of alcohol-induced pain strongly points to Hodgkin Lymphoma.

Mo

Depth

Full handout

High yield triage

Etiology / Epidemiology

Bimodal age distribution (20s and >50s). Associated with Epstein-Barr virus infection.

Clinical Manifestations

Painless cervical/supraclavicular lymphadenopathy and Pel-Ebstein fever.

Diagnosis

Excisional lymph node biopsy showing Reed-Sternberg cells.

Treatment

ABVD regimen (Adriamycin, Bleomycin, Vinblastine, Dacarbazine).

Prognosis

Highly curable; 80-90% 5-year survival rate in early stages.

Full handout

Epidemiology & Etiology

Bimodal distribution peaks in young adults (20-30) and older adults (>50). Strong association with Epstein-Barr virus (EBV) in up to 50% of cases. Increased risk in patients with HIV or history of immunosuppression.

Pertinent Anatomy

Typically originates in a single lymph node chain, most commonly the cervical or supraclavicular nodes. Spreads in a predictable, contiguous fashion to adjacent lymph node groups.

Pathophysiology

Malignant transformation of B-lymphocytes leads to the formation of Reed-Sternberg cells. These cells secrete cytokines that recruit inflammatory cells, creating the characteristic inflammatory milieu. The disease is defined by the presence of these cells in a background of reactive lymphocytes.

Clinical Manifestations

Painless, rubbery lymphadenopathy is the hallmark. Patients may present with B symptoms: fever, night sweats, and weight loss >10%. Alcohol-induced pain at the site of lymphadenopathy is a rare but highly specific finding. Pel-Ebstein fever (cyclic fever) is a classic, though uncommon, presentation.

Diagnosis

Excisional lymph node biopsy is the gold standard for diagnosis. Histology must demonstrate Reed-Sternberg cells (large, multinucleated cells with 'owl-eye' appearance). PET/CT scan is required for staging to assess metabolic activity and disease extent.

Treatment

Standard of care is the ABVD regimen. Bleomycin carries a risk of pulmonary fibrosis, requiring baseline and serial pulmonary function tests. Radiation therapy is often used as an adjunct in localized disease. Secondary malignancies are a long-term concern for survivors.

Prognosis

Highly curable with modern chemotherapy and radiation. 80-90% 5-year survival rate. Long-term survivors require monitoring for cardiovascular disease and secondary cancers (breast, lung) due to prior radiation exposure.

Differential Diagnosis

Non-Hodgkin Lymphoma: usually presents with extranodal involvement and non-contiguous spread

Infectious Mononucleosis: acute onset with pharyngitis and positive heterophile antibody

Tuberculosis: associated with night sweats and pulmonary findings on CXR

Sarcoidosis: bilateral hilar adenopathy without Reed-Sternberg cells

Metastatic Carcinoma: usually older patients with a known primary site